Peptide

IGF-1 DES

Also known as

Des(1-3)IGF-1 · DES(1-3) IGF-1 · des(1-3)IGF-I · IGF1 DES · IGF-DES · IGF DES 1,3 · IGF-1 DES 1-3 · des-IGF-1 · Des-IGF-1 · truncated IGF-1 · rHuDES(1-3)IGF-1

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Identity	A shortened IGF-1 research peptide, usually discussed as an injection around trained muscles. The claim that a muscle-site injection selectively grows that muscle remains disputed.

Notes

IGF-1 DES is a shortened IGF-1 research peptide discussed for muscle pumps, lagging body parts and recovery. Reports range from fuller muscles and perceived improvement to no extra effect or more soreness. The claim that injecting a muscle selectively grows it remains disputed and unproven in these accounts.

A shortened growth factor. DES means des(1–3): the first three building blocks of IGF-1 are removed, leaving 67 rather than 70 amino acids. It binds less to proteins that normally carry IGF. Gym discussions contrast this with IGF-1 LR3, framing DES as a brief muscle-site exposure rather than prolonged coverage. Information related to IGF-1 LR3, IGF-1 des (Secondhand community claim · Accessed 2026-09-30)

The local-growth idea. People usually describe intramuscular (IM) use in a trained muscle; subcutaneous (SC) use also appears. The aim is bringing up a lagging body part. Injection location does not establish that activity stays there, and users dispute whether site-specific growth happens at all. DES is distinct from HGH, insulin and clinical mecasermin. IGf1 des (Community discussion · Accessed 2026-09-30) · INCRELEX (mecasermin) prescribing information (Official context · Accessed 2026-09-30)

Source context — Information related to IGF-1 LR3, IGF-1 des: Sponsor-adjacent compilation with copied/promotional assertions. No human kinetic measurement, personal log or evidence establishing local hyperplasia; daily and per-use amounts must not be conflated.

Source context — IGf1 des: Opinions and personal reports coexist; some comments promote vendors. Collapsed dose/duration replies were not accessible, so the one-hour pump detail is preserved from the frozen profile rather than claimed freshly inspected.

Source context — INCRELEX (mecasermin) prescribing information: Native IGF-1 product used in pediatric patients, not DES. Supplies class context only; no DES dosing, event rate or cancer causality is inferred.

What people notice

Pumps and appearance	Some describe fuller muscles, stronger pumps or better definition. A temporary pump does not demonstrate new muscle fibers.
Recovery can disappoint	One user credited shoulder comfort; another's stronger pump came with fewer shoulder-press reps and unusual soreness. Feeling fuller and performing better are different outcomes.

Notes

Fullness and muscle development. The appeal is a stronger pump, more definition and better development of shoulders, arms, calves or chest. These are subjective reports; training volume, food, water and other drugs can explain part of the change. A temporary pump is not evidence of new muscle fibers. IGF DES experiences (Community discussion · Accessed 2026-09-30) · IGf1 des (Community discussion · Accessed 2026-09-30)

Positive and unchanged reports coexist. One disabled user credited DES with broader muscle definition and shoulder comfort; another described a modest pump and next-morning fat-loss impression. Separate commenters saw no extra pump or suspected ineffective products. Those suspicions are unresolved, rather than proof that null experiences were fake. IGF DES experiences (Community discussion · Accessed 2026-09-30)

Recovery and injury talk. One person credited DES with better rotator-cuff symptoms and quality of life, including changes outside injected muscles. Older accounts describe less next-session soreness and soft-tissue recovery, often alongside BPC-157 or TB-500. Neither story establishes tendon healing or a predictable repair time. IGF DES experiences (Community discussion · Accessed 2026-09-30)

A pump can accompany a worse workout. After 25 mcg in the deltoid, one author described dropping from 6–8 shoulder-press reps to 3, while the pump felt stronger. They also reported unusually sore biceps and chest. A reply raised injection irritation as an alternative explanation. Feeling fuller and performing better are different outcomes. IGF-1 DES working against me? (Personal report · Accessed 2026-09-30)

Source context — IGF DES experiences: Unverified products and uncontrolled reports; deleted author and FistedAmbitions are separate accounts. Collapsed replies not inspected. Speculative schedules are not measured cycles.

Source context — IGF-1 DES working against me?: Single unverified account; username suggests possible commercial involvement but affiliation is not established. No controlled strength comparison or glucose data.

Doses people talk about

Intramuscular accounts	Separate reports describe 25 mcg before training, 30–50 mcg pre-workout, or 25 mcg per quad—50 mcg total—on two leg days weekly. Their outcomes differ.
Per site versus total	Older talk spans 20–100 mcg/site versus 50–150 mcg/session; one newer thread discusses 40–80 mcg total split bilaterally. More sites change the total, and ambiguous labels cannot be treated as equivalent.
Daily and training-day charts	Different charts give 20–50 mcg subcutaneously once daily or 50–150 mcg/day IM/SC, while some list repeated daily administrations. Older training-day patterns are roughly 3–5 days/week. No validated ceiling emerges.

Notes

Actual amounts in reports. A one-week account used 25 mcg IM before training and reported poorer performance. Another described 30–50 mcg IM pre-workout with a noticeable pump. A commercial biohacking guide describes 25 mcg per quad, 50 mcg total, on two leg-training days weekly. These are reports, not a recommended range. IGF-1 DES working against me? (Personal report · Accessed 2026-09-30) · IGF DES experiences (Community discussion · Accessed 2026-09-30) · How to Use IGF-Des In 2024 (Ultimate IGF-Des Guide!!) (Community guide · Accessed 2026-09-30)

Per site is different from a session total. Older discussion spans 20–100 mcg/site versus 50–150 mcg/session, with examples of 20–50 mcg/injection, 40–60 or 50–80 mcg/side, and higher claims of 75–100 mcg/injection or 100–120 mcg per bilateral muscle group. The 2023 thread discusses 40–80 mcg total and splitting it bilaterally. Labels are inconsistent; adding sites changes the total. IGf1 des (Community discussion · Accessed 2026-09-30)

Daily charts disagree. A shop-linked guide lists 50–150 mcg/day IM or SC; a sponsor-adjacent forum compilation says 50–150 mcg multiple times daily. Older charts include 20–50 mcg SC once daily and a supposed 100 mcg/day ceiling. These describe different practices, with no validated safety ceiling. A Complete Guide for IGF1-DES (Community guide · Accessed 2026-09-30) · Information related to IGF-1 LR3, IGF-1 des (Secondhand community claim · Accessed 2026-09-30)

Frequency and higher claims. Older training-day patterns run roughly 3–5 days/week, usually once around training; injury/advanced charts mention daily or twice-daily use. One person reported amounts up to 250 mcg without trusting the product. A high claimed amount or absent sensation cannot confirm identity, potency or tolerance. IGF DES experiences (Community discussion · Accessed 2026-09-30)

Source context — How to Use IGF-Des In 2024 (Ultimate IGF-Des Guide!!): Commercial affiliate guide, not an independent trial. Dose tiers have ambiguous per-site versus total framing; not repeated as a recommended progression. Follow-up route is uncertain.

Source context — A Complete Guide for IGF1-DES: Commercial community guide makes unsupported disease-benefit and safety claims. Comments asking whether healing occurred supply no outcome. Proposed six-month bone-growth use is a plan, not a completed result.

Half-life, onset & duration

Felt onset	Some notice an extra pump in the same workout; others do not. Older accounts place fuller-feeling muscles at 3–7 days and subjective shape changes at weeks 2–4, without measured growth milestones.
Felt duration	One older account describes about an hour of pump. A DES-plus-PEG-MGF report describes feeling hypoglycemic for a couple of hours; these are separate sensations, not clearance measurements.
Half-life	10–20, 20–30 and roughly 30 minutes circulate, alongside older 2–5-minute lore. None is a checked human DES concentration-time measurement here; a rat clearance study does not supply that value.

Notes

Same-workout effects vary. Some describe an extra pump during the session; another reported none after 25 mcg and more soreness the next day. Before-, during- and immediately-after-workout camps coexist. These accounts do not identify an optimal onset window or prove a particular route was responsible. IGf1 des (Community discussion · Accessed 2026-09-30) · How to Use IGF-Des In 2024 (Ultimate IGF-Des Guide!!) (Community guide · Accessed 2026-09-30) · IGF-1 DES working against me? (Personal report · Accessed 2026-09-30)

Appearance takes longer, when reported. Older summaries place fuller-feeling muscles within 3–7 days and subjective regional size/shape changes around weeks 2–4. These are historical community timelines, not measured growth milestones; unchanged experiences also occur. IGF DES experiences (Community discussion · Accessed 2026-09-30)

A pump is a short-lived sensation. An earlier community account describes a roughly one-hour pump/vascularity report around a claimed 50 mcg injection. That detail was not visible in the freshly opened thread's collapsed replies. It describes a sensation, not elimination half-life or proven growth lasting an hour.

Unwanted effects can outlast the claimed half-life. A preserved 150–200 mcg DES-plus-PEG-MGF account describes feeling hypoglycemic for a couple of hours, with less trouble around 80 mcg total. Another freshly opened account describes soreness over following days. Durable gains after stopping and the duration of any repair effect remain unknown. IGF-1 DES working against me? (Personal report · Accessed 2026-09-30)

Minutes-scale figures circulate. Forums and guides repeat 20–30 minutes or about 30 minutes; an older IronMag post says 10–20 minutes. Earlier community reports include 2–5-minute human degradation lore. None is a checked human DES concentration-time measurement. Their original human basis is unresolved; rat clearance context stays separate below. Information related to IGF-1 LR3, IGF-1 des (Secondhand community claim · Accessed 2026-09-30) · IGF-1 DES (Personal report · Accessed 2026-09-30) · Is igf-1 DES much better then igf1-LR3? — page 2 (Community opinion · Accessed 2026-09-30)

Rat clearance is separate context. A 1991 IV tracer study in rats reported DES clearance of 4.59 ml/min/kg versus 1.20 for native IGF-I, with radioactivity distributed across tissues. This supports altered binding and disposition. It supplies neither a human minutes-scale half-life nor proof that an IM shot acts only locally. Plasma clearance and tissue distribution of labelled IGF-I, IGF-II and des(1-3)IGF-I in rats (Animal context · Accessed 2026-09-30)

Source context — IGF-1 DES: Author discusses peptide-business testing elsewhere in the thread; possible commercial interest. No objective glucose data; stated personal tolerance cannot assure safety.

Source context — Is igf-1 DES much better then igf1-LR3? — page 2: Bodybuilding opinion with commercial signatures; no human concentration-time data. Potency rankings and insulin-stack advice are unsupported and not adopted.

Source context — Plasma clearance and tissue distribution of labelled IGF-I, IGF-II and des(1-3)IGF-I in rats: Abstract-only access. PubMed and Europe PMC web opens failed; API abstract was successfully read. Rat IV tracer clearance is not human IM/SC half-life or local-only exposure.

Cycles people discuss

Competing calendars	Guides describe 3–4 weeks or 30 days with at least two weeks off. Older charts include 4–6 or 4–8 weeks and 2–4-week injury-stack blocks; break conventions do not establish restored sensitivity or safety.

Notes

Published calendars are inconsistent. The commercial biohacking guide caps use at 3–4 weeks; the shop-linked guide gives 30 days and at least two weeks off. Older records retain separate 4–6-week charts and 4–8-week extended runs, plus 2–4-week injury-stack blocks. Course length is not single-dose duration. How to Use IGF-Des In 2024 (Ultimate IGF-Des Guide!!) (Community guide · Accessed 2026-09-30) · A Complete Guide for IGF1-DES (Community guide · Accessed 2026-09-30)

Reasons for breaks remain speculative. Older talk includes 2–4 weeks off, time off at least as long as time on, and 4 weeks on/4 weeks off. Receptor-desensitization and satellite-cell-depletion stories motivate these patterns. A 2019 commenter proposing 1–2-week DES/MGF alternation admitted never trying DES. No pattern establishes restored sensitivity or safe repeated use. IGF DES experiences (Community discussion · Accessed 2026-09-30)

Stacks

Growth-factor and hormone stacks	LR3, MGF/PEG-MGF, HGH, MK-677, CJC/Ipamorelin, androgens and insulin appear. Older charts also pair carbohydrate intake with the dose window; no spacing or food rule establishes protection.
Injury-peptide stacks	BPC-157 and TB-500 appear in recovery stories. Those combined accounts cannot establish DES-specific tendon healing or a predictable repair time.

Notes

Stacks make the story harder to interpret. Discussion combines DES with LR3, MGF/PEG-MGF, HGH, MK-677, CJC/Ipamorelin, androgens, insulin or injury peptides. Older charts pair roughly 30–50 g carbohydrate with the dose window. These combinations and meal changes confound attribution; debated growth-factor spacing is not a proven synergy or protection strategy. IGf1 Des and Peg MGF — Cycling together at different times of the same day (Community discussion · Accessed 2026-09-30)

DES + BPC-157 ± TB-500: Injury / soft-tissue recovery stack — DES for local anabolic/satellite talk, BPC/TB for repair-inflammation lore; sample injury charts sometimes use lower DES (~20–40 mcg near site) with BPC ~250–500 mcg and TB weekly loads that vary widely. [community]

Source context — IGf1 Des and Peg MGF — Cycling together at different times of the same day: Same author as the 2023 timing thread, not an independent additional responder. No objective results or completed combination course; assertions that either DES or MGF is safe are not adopted.

Watch for

Glucose and injections	Feeling hypoglycemic appears in mixed reports. Repeated injections add pain, bruising, infection and nerve/vessel concerns; some users describe more soreness and poorer training.
Growth and safety claims	Short-half-life claims do not show that activity stays local or rule out organ/tumor concerns. Mecasermin's severe-hypoglycemia and malignancy cautions are separate IGF context, without a DES risk rate. IGF analogues are prohibited in tested sport.

Notes

Glucose and injection problems. Feeling hypoglycemic appears in combination reports, while other users describe no glucose problems. Food/carbohydrate pairing is discussed, but does not assure protection. Repeated injections add pain, bruising, infection and nerve/vessel concerns; increased soreness can reduce useful training. IGF-1 DES working against me? (Personal report · Accessed 2026-09-30) · IGF-1 DES (Personal report · Accessed 2026-09-30)

Growth signaling is not confined by a forum claim. Short-half-life assurances about avoiding organ or tumor effects are unsupported. The native-IGF-1 mecasermin label records severe hypoglycemia and malignancy-related cautions; it does not quantify DES risk. Confusion, seizures or unconsciousness need emergency help. INCRELEX (mecasermin) prescribing information (Official context · Accessed 2026-09-30) · IGf1 Des and Peg MGF — Cycling together at different times of the same day (Community discussion · Accessed 2026-09-30)

Tested sport. WADA lists IGF-1 and its analogues as prohibited at all times. A short-half-life story is not a clearance or detection-window guarantee. The Prohibited List — S2.3 growth factors (Official context · Accessed 2026-09-30)

Source context — The Prohibited List — S2.3 growth factors: Sport rule, not a clinical safety judgment or a detection-window measurement.

Full notes

What IGF-1 DES is

A shortened growth factor. DES means des(1–3): the first three building blocks of IGF-1 are removed, leaving 67 rather than 70 amino acids. It binds less to proteins that normally carry IGF. Gym discussions contrast this with IGF-1 LR3, framing DES as a brief muscle-site exposure rather than prolonged coverage. Jacked Forums
The local-growth idea. People usually describe intramuscular (IM) use in a trained muscle; subcutaneous (SC) use also appears. The aim is bringing up a lagging body part. Injection location does not establish that activity stays there, and users dispute whether site-specific growth happens at all. DES is distinct from HGH, insulin and clinical mecasermin. Reddit r/Peptides Community Official context

Why people look it up

Fullness and muscle development. The appeal is a stronger pump, more definition and better development of shoulders, arms, calves or chest. These are subjective reports; training volume, food, water and other drugs can explain part of the change. A temporary pump is not evidence of new muscle fibers. Reddit r/Peptides Reddit r/Peptides Community
Recovery and injury talk. One person credited DES with better rotator-cuff symptoms and quality of life, including changes outside injected muscles. Older accounts describe less next-session soreness and soft-tissue recovery, often alongside BPC-157 or TB-500. Neither story establishes tendon healing or a predictable repair time. Reddit r/Peptides Community

Doses people discuss

Actual amounts in reports. A one-week account used 25 mcg IM before training and reported poorer performance. Another described 30–50 mcg IM pre-workout with a noticeable pump. A commercial biohacking guide describes 25 mcg per quad, 50 mcg total, on two leg-training days weekly. These are reports, not a recommended range. Personal report Reddit r/Peptides Community guide
Per site is different from a session total. Older discussion spans 20–100 mcg/site versus 50–150 mcg/session, with examples of 20–50 mcg/injection, 40–60 or 50–80 mcg/side, and higher claims of 75–100 mcg/injection or 100–120 mcg per bilateral muscle group. The 2023 thread discusses 40–80 mcg total and splitting it bilaterally. Labels are inconsistent; adding sites changes the total. Community Reddit r/Peptides
Daily charts disagree. A shop-linked guide lists 50–150 mcg/day IM or SC; a sponsor-adjacent forum compilation says 50–150 mcg multiple times daily. Older charts include 20–50 mcg SC once daily and a supposed 100 mcg/day ceiling. These describe different practices, with no validated safety ceiling. Community guide Jacked Forums Community
Frequency and higher claims. Older training-day patterns run roughly 3–5 days/week, usually once around training; injury/advanced charts mention daily or twice-daily use. One person reported amounts up to 250 mcg without trusting the product. A high claimed amount or absent sensation cannot confirm identity, potency or tolerance. Community Reddit r/Peptides

Half-life: claims versus measurements

Minutes-scale figures circulate. Forums and guides repeat 20–30 minutes or about 30 minutes; an older IronMag post says 10–20 minutes. Earlier community reports include 2–5-minute human degradation lore. None is a checked human DES concentration-time measurement. Their original human basis is unresolved; rat clearance context stays separate below. Jacked Forums Personal report IronMag Bodybuilding Forums Community
Half-life does not mean completely gone. A Reddit discussion arose because someone thought the short figure required repeated injections throughout a workout. Replies correctly distinguish halving from disappearance. Even a valid elimination figure would not measure the length of a pump, tissue signaling or unwanted effects. Reddit r/Peptides

Onset: when people notice something

Same-workout effects vary. Some describe an extra pump during the session; another reported none after 25 mcg and more soreness the next day. Before-, during- and immediately-after-workout camps coexist. These accounts do not identify an optimal onset window or prove a particular route was responsible. Reddit r/Peptides Community guide Personal report
Appearance takes longer, when reported. Older summaries place fuller-feeling muscles within 3–7 days and subjective regional size/shape changes around weeks 2–4. These are historical community timelines, not measured growth milestones; unchanged experiences also occur. Community Reddit r/Peptides

Duration: how long the reported change lasts

A pump is a short-lived sensation. An earlier community account describes a roughly one-hour pump/vascularity report around a claimed 50 mcg injection. That detail was not visible in the freshly opened thread's collapsed replies. It describes a sensation, not elimination half-life or proven growth lasting an hour. Community
Unwanted effects can outlast the claimed half-life. A preserved 150–200 mcg DES-plus-PEG-MGF account describes feeling hypoglycemic for a couple of hours, with less trouble around 80 mcg total. Another freshly opened account describes soreness over following days. Durable gains after stopping and the duration of any repair effect remain unknown. Community Personal report

Cycles and time off

Published calendars are inconsistent. The commercial biohacking guide caps use at 3–4 weeks; the shop-linked guide gives 30 days and at least two weeks off. Older records retain separate 4–6-week charts and 4–8-week extended runs, plus 2–4-week injury-stack blocks. Course length is not single-dose duration. Community guide Community guide Community
Reasons for breaks remain speculative. Older talk includes 2–4 weeks off, time off at least as long as time on, and 4 weeks on/4 weeks off. Receptor-desensitization and satellite-cell-depletion stories motivate these patterns. A 2019 commenter proposing 1–2-week DES/MGF alternation admitted never trying DES. No pattern establishes restored sensitivity or safe repeated use. Community Reddit r/Peptides

What could change the decision

Glucose and injection problems. Feeling hypoglycemic appears in combination reports, while other users describe no glucose problems. Food/carbohydrate pairing is discussed, but does not assure protection. Repeated injections add pain, bruising, infection and nerve/vessel concerns; increased soreness can reduce useful training. Community Personal report Personal report
Growth signaling is not confined by a forum claim. Short-half-life assurances about avoiding organ or tumor effects are unsupported. The native-IGF-1 mecasermin label records severe hypoglycemia and malignancy-related cautions; it does not quantify DES risk. Confusion, seizures or unconsciousness need emergency help. Official context Reddit r/Peptides Community
Other complaints and product uncertainty. Older reports include puffiness, headache, nausea, fatigue and joint aches in mixed stacks, plus concern about disproportionate tissue growth or stiffness. Unverified identity, concentration and contamination complicate both benefit and harm reports. No controlled DES safety course was identified. Community Reddit r/Peptides
Tested sport. WADA lists IGF-1 and its analogues as prohibited at all times. A short-half-life story is not a clearance or detection-window guarantee. Official context

What the community accounts show

A pump can accompany a worse workout. After 25 mcg in the deltoid, one author described dropping from 6–8 shoulder-press reps to 3, while the pump felt stronger. They also reported unusually sore biceps and chest. A reply raised injection irritation as an alternative explanation. Feeling fuller and performing better are different outcomes. Personal report
Positive and unchanged reports coexist. One disabled user credited DES with broader muscle definition and shoulder comfort; another described a modest pump and next-morning fat-loss impression. Separate commenters saw no extra pump or suspected ineffective products. Those suspicions are unresolved, rather than proof that null experiences were fake. Reddit r/Peptides
Locality and logistics are a real tradeoff. A shoulder-focused user credited better definition but described burdensome repeated injections. Other posters argue that both DES and LR3 become systemic, or reject site-growth claims entirely. Multi-site effort is tangible; a preferential growth effect has not been demonstrated by these comparisons. Reddit r/Peptides IronMag Bodybuilding Forums
Stacks make the story harder to interpret. Discussion combines DES with LR3, MGF/PEG-MGF, HGH, MK-677, CJC/Ipamorelin, androgens, insulin or injury peptides. Older charts pair roughly 30–50 g carbohydrate with the dose window. These combinations and meal changes confound attribution; debated growth-factor spacing is not a proven synergy or protection strategy. Community Community Reddit r/Peptides

What the supporting research can tell us

Rat clearance is separate context. A 1991 IV tracer study in rats reported DES clearance of 4.59 ml/min/kg versus 1.20 for native IGF-I, with radioactivity distributed across tissues. This supports altered binding and disposition. It supplies neither a human minutes-scale half-life nor proof that an IM shot acts only locally. Animal context